Page 11

Working Ranch - November/December 2017

Learn more at Zelnate.com True strength comes from within Help the animal help itself™ Use the power of innate immunity to fight BRD Zelnate® DNA Immunostimulant jumpstarts the innate immune system to help reduce lung lesions and mortality in cattle due to BRD associated with Mannheimia haemolytica. In fact, adding Zelnate to your current BRD protocol has been proven to lower mortality by 22%, regardless of an on-arrival or delayed modified live vaccine.1 Zelnate is indicated for use as an aid in the treatment of BRD due to Mannheimia haemolytica in cattle 4 months of age or older, when administered at the time of, or within 24 hours after, a perceived stressful event. This product is based on technology developed by Juvaris BioTherapeutics and is patent protected. Animal health applications are being exclusively developed by Bayer Animal Health and are the subject of Bayer patent applications. 1 Rogers KC, Miles DG, Renter DG, et al. (2016). Effects of delayed respiratory viral vaccine and/or inclusion of an immunostimulant on feedlot health, performance, and carcass merits of auction-market derived feeder heifers. Bovine Practitioner. 50(2):154-162. ©2017 Bayer, Shawnee Mission, Kansas 66201. Bayer (reg’d), the Bayer Cross (reg’d), Zelnate® and Help the animal help itself™ are trademarks of Bayer. ZNT171580


Working Ranch - November/December 2017
To see the actual publication please follow the link above